Xiaohong She - Adagene Senior Operations
| ADAG Stock | USD 2.60 0.04 1.52% |
Executive
Xiaohong She is Senior Operations of Adagene
| Age | 57 |
| Address | Building C14, Suzhou, China, 215123 |
| Phone | 86 512 8777 3632 |
| Web | https://www.adagene.com |
Adagene Management Efficiency
The company has return on total asset (ROA) of (0.1106) % which means that it has lost $0.1106 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2466) %, meaning that it created substantial loss on money invested by shareholders. Adagene's management efficiency ratios could be used to measure how well Adagene manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.17. The current Return On Capital Employed is estimated to decrease to -0.34. At this time, Adagene's Non Current Assets Total are most likely to increase significantly in the upcoming years. The Adagene's current Non Currrent Assets Other is estimated to increase to about 89.1 K, while Return On Tangible Assets are projected to decrease to (0.17).Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Eric Loumeau | AnaptysBio | 61 | |
| Joshua JD | AN2 Therapeutics | 46 | |
| Gopal MBBS | Rezolute | N/A | |
| Daron Evans | Rezolute | 50 | |
| Sankaram Mantripragada | Rezolute | 56 | |
| Anne DVM | Molecular Partners AG | N/A | |
| Stephen Yu | Aerovate Therapeutics | N/A | |
| MD MBA | Molecular Partners AG | N/A | |
| CPA CFA | Janux Therapeutics | 47 | |
| Dr MBA | Acrivon Therapeutics Common | N/A | |
| Morgan Fields | Rezolute | 36 | |
| Robert McKean | Mineralys Therapeutics Common | N/A | |
| Jennifer Huber | AN2 Therapeutics | N/A | |
| Robert Ticktin | Pmv PharmaceuticalsInc | 62 | |
| Benjamin Stone | AnaptysBio | N/A | |
| Susan Fischer | Aerovate Therapeutics | N/A | |
| Beth Mueller | AnaptysBio | N/A | |
| Valerie Morisset | Eliem Therapeutics | 54 | |
| Michael Deperro | Rezolute | N/A | |
| Binh Vu | Pmv PharmaceuticalsInc | N/A | |
| Danielle Bradbury | Mineralys Therapeutics Common | N/A | |
Management Performance
| Return On Equity | -0.25 | ||||
| Return On Asset | -0.11 |
Adagene Leadership Team
Elected by the shareholders, the Adagene's board of directors comprises two types of representatives: Adagene inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Adagene. The board's role is to monitor Adagene's management team and ensure that shareholders' interests are well served. Adagene's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Adagene's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Guizhong Liu, Head Pharmacology | ||
| Xiaohong She, Senior Operations | ||
| Ling Zhou, Head Resources | ||
| Man MBA, CFO Director | ||
| Alexander Goergen, VP Development | ||
| Qinghai Zhao, Chief Officer | ||
| Fangyong Du, Chief Officer | ||
| Ami Knoefler, Vice Communications | ||
| Peter Luo, Chairman, Founder | ||
| Yan MBA, Senior Director | ||
| Jc MD, Chief Officer |
Adagene Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Adagene a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.25 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (1.05) % | ||||
| Operating Margin | (22.89) % | ||||
| Current Valuation | 58.31 M | ||||
| Shares Outstanding | 44.16 M | ||||
| Shares Owned By Insiders | 4.18 % | ||||
| Shares Owned By Institutions | 16.13 % | ||||
| Number Of Shares Shorted | 13.69 K | ||||
| Price To Book | 1.65 X |
Pair Trading with Adagene
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Adagene position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adagene will appreciate offsetting losses from the drop in the long position's value.Moving against Adagene Stock
| 0.68 | INDP | Indaptus Therapeutics Financial Report 9th of May 2024 | PairCorr |
| 0.67 | RZLT | Rezolute Trending | PairCorr |
| 0.63 | NVO | Novo Nordisk AS Financial Report 2nd of May 2024 | PairCorr |
| 0.61 | CELC | Celcuity LLC Financial Report 20th of May 2024 | PairCorr |
| 0.55 | BMY | Bristol Myers Squibb Financial Report 25th of April 2024 | PairCorr |
The ability to find closely correlated positions to Adagene could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Adagene when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Adagene - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Adagene to buy it.
The correlation of Adagene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adagene moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adagene moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Adagene can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adagene. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more detail on how to invest in Adagene Stock please use our How to Invest in Adagene guide.Note that the Adagene information on this page should be used as a complementary analysis to other Adagene's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Complementary Tools for Adagene Stock analysis
When running Adagene's price analysis, check to measure Adagene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adagene is operating at the current time. Most of Adagene's value examination focuses on studying past and present price action to predict the probability of Adagene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adagene's price. Additionally, you may evaluate how the addition of Adagene to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is Adagene's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adagene. If investors know Adagene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adagene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.44) | Revenue Per Share 0.414 | Quarterly Revenue Growth (0.85) | Return On Assets (0.11) | Return On Equity (0.25) |
The market value of Adagene is measured differently than its book value, which is the value of Adagene that is recorded on the company's balance sheet. Investors also form their own opinion of Adagene's value that differs from its market value or its book value, called intrinsic value, which is Adagene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adagene's market value can be influenced by many factors that don't directly affect Adagene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adagene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Adagene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adagene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.